Noteworthy, levels of insulin/IGF-1 receptors are decreased in AD brains (Steen et al., 2005), and APP processing and Aβ production in vitro was modulated by insulin signaling (Gasparini et al., 2001). Here, INS is linked to Alzheimer disease.